HUMAN-FIRST DISCOVERY Trademark

Trademark Overview


On Monday, September 24, 2018, a trademark application was filed for HUMAN-FIRST DISCOVERY with the United States Patent and Trademark Office. The USPTO has given the HUMAN-FIRST DISCOVERY trademark a serial number of 88129594. The federal status of this trademark filing is REGISTERED as of Tuesday, October 1, 2019. This trademark is owned by Finch Therapeutics, Inc.. The HUMAN-FIRST DISCOVERY trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of microbiologics, immunotherapeutics, and other therapeutic agents; development of pharmaceuticals, diagnostics, food additives, dietary supplements, medical foods, foods for special dietary use; scientific research and development services relating to foods and dietary supplements; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto
human-first discovery

General Information


Serial Number88129594
Word MarkHUMAN-FIRST DISCOVERY
Filing DateMonday, September 24, 2018
Status700 - REGISTERED
Status DateTuesday, October 1, 2019
Registration Number5875631
Registration DateTuesday, October 1, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 4, 2018

Trademark Statements


NOT AVAILABLE"DISCOVERY"
Goods and ServicesResearch and development of microbiologics, immunotherapeutics, and other therapeutic agents; development of pharmaceuticals, diagnostics, food additives, dietary supplements, medical foods, foods for special dietary use; scientific research and development services relating to foods and dietary supplements; providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSaturday, September 29, 2018
Primary Code042
First Use Anywhere DateFriday, January 6, 2017
First Use In Commerce DateFriday, January 6, 2017

Trademark Owner History


Party NameFinch Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSomerville, MA 02143

Party NameFinch Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSomerville, MA 02143

Party NameFinch Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSomerville, MA 02143

Trademark Events


Event DateEvent Description
Wednesday, October 10, 2018ASSIGNED TO EXAMINER
Monday, October 15, 2018EXAMINERS AMENDMENT E-MAILED
Monday, October 15, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 15, 2018EXAMINER'S AMENDMENT ENTERED
Thursday, September 27, 2018NEW APPLICATION ENTERED
Saturday, September 29, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 15, 2018EXAMINERS AMENDMENT -WRITTEN
Monday, October 15, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, October 27, 2018ASSIGNED TO LIE
Thursday, July 25, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, July 25, 2019USE AMENDMENT FILED
Thursday, November 1, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, November 14, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 4, 2018PUBLISHED FOR OPPOSITION
Tuesday, December 4, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 29, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 22, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 22, 2019STATEMENT OF USE PROCESSING COMPLETE
Thursday, August 29, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 30, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 1, 2019REGISTERED-PRINCIPAL REGISTER
Tuesday, October 1, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED